You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Development and Characterization of the Patient-Friendly Formulations: Preparation and Characterization of a Suspension Containing Nanoparticulated Rebamipide for Stomatitis
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-C-013-Tuesday
- By: HANAWA, Takehisa (Tokyo University of Science, Faculty of Pharmaceutical Sciences, Noda-City, Japan)
- Co-author(s): Yayoi Kawano: Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda-City, Japan
Naoko Ishii: Dept. of Pharmacy, Kashiwa City Hospital, Kashiwa-City, Japan
Yuichiro Shimizu: Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda-City, Japan
Takehisa Hanawa: Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda-City, Japan - Abstract:
Backgrounds
Aphthous stomatitis is known to be induced by chemotherapy and radiotherapy. One hundred percent of patients administered high-dose chemotherapy and 80% of patients receiving radiotherapy develop stomatitis. Furthermore, it has been reported that stomatitis is a prominent clinical problem affecting approximately 40% of patients.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026